Practitioner’s guide to valuation in the pharmaceutical, biotechnology, diagnostics, medical devices and wider life sciences and healthcare sector- get acquainted with state-of-the-art concepts and practices.
Mastering the Valuation of Pharma and Biotech Assets and Businesses Properly valuing drug and biotechnology assets is essential for pharmaceutical enterprises, biotech companies, investors, and other healthcare stakeholders. Valuation provides…
Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…
Key Factors in Venture Capital Valuation of Healthcare and Life Sciences Startups Valuing early-stage healthcare and life sciences startups presents unique challenges due to their lack of revenue, high-risk profiles,…
Leveraging EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and prioritization, licensing…
Leveraging Biotech Valuation Multiples for Accurate Biopharma Company Valuations Valuation of biotech companies, assets, and programs is often required for a multitude of purposes. The biotech valuation multiples is a…
Criteria and Strategies for Choosing the Right Comparable Companies in Biotech Valuation When valuing a private or public biotech company using market multiples, one of the most critical first steps…
How to Determine an Accurate Addressable Market Size in Life Sciences Commercial Due Diligence Market size is one of the critical elements in the life sciences commercial due diligence, new…
How to Navigate the Discount Rate Conundrum in Biotech and Pharma Valuation In the pharmaceutical and biotechnology industry (referred to collectively as biopharma), almost all valuation and investment decisions decisions…
How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…
How to Address Terminal Value Challenges in Pharmaceutical Asset Valuation Several stakeholders who have an interest in pharmaceutical assets employ a multitude of methods to conduct valuations. Among various valuation…